Sort
82,697 grants matching “vaccine development”
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,209,674Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2022 · AI
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
$2,209,541James Culvin Morris · Clemson University · P20 · FY2022 · GM
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$2,209,409Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Host Pathogen Variation & TB Pathogenesis
$2,209,347Thomas R Hawn · University Of Washington · U19 · FY2025 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,208,763Pamela J Bjorkman · California Institute Of Technology · P01 · FY2023 · AI
Flavivirus Infections: Pathogenesis and Prevention
$2,208,691Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · AI
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$2,207,796Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Epigenomic analysis of primary immune cells from young and old animals
$2,207,621Myong-Hee Sung · National Institute On Aging · ZIA · FY2022 · AG
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$2,207,151Mark M Davis · Stanford University · U19 · FY2023 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$2,206,711Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2020 · GM
Sexually Transmitted Infections Clinical Trials Group
$2,206,296Torrise Woody · California Univ San Franc · N01 · FY2011 · AI
Flow Cytometry Core
$2,206,040Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
POLLEN GRAINS AS TROJAN HORSES FOR ORAL VACCINATION
$2,205,000Harvinder Singh Gill · Texas Tech University · DP2 · FY2012 · HD
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
$2,204,524James Culvin Morris · Clemson University · P20 · FY2024 · GM
B Cells in Health and Disease
$2,204,218Ignacio E. Sanz · Emory University · P01 · FY2012 · AI
HIV Preventive Vaccine Studies
$2,204,214Barney Scott Graham · Niaid Extramural Activities · Z01 · FY2007 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$2,204,090Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2022 · GM
PDT - Mechanisms and Strategies for Optimization
$2,203,933Barbara W. Henderson · Roswell Park Cancer Institute Corp · P01 · FY2009 · CA
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,203,749Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections- Small Clinical Trials Unit (SCTU)
$2,203,379Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$2,203,024Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,202,898Stephen C Harrison · Boston Children'S Hospital · P01 · FY2011 · AI
An oral vaccine against Chlamydia trachomatis
$2,202,675Guangming Zhong · University Of Texas Hlth Science Center · U01 · FY2024 · AI
Vaccine Induced Immunity in the Young and Aged
$2,202,644Rafi Ahmed · Emory University · U19 · FY2023 · AI
Novel Adenovirus Vector-Based Vaccines for HIV-1
$2,202,559Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI